Stock research
FTH Faeth Therapeutics, Inc.
Healthcare • Biotechnology
Faeth Therapeutics, Inc. is a clinical-stage biotechnology company focused on improving outcomes for cancer patients through multi-node inhibition of critical oncogenic pathways. [28, 70] The company's lead program,...…
Faeth Therapeutics, Inc. is a clinical-stage biotechnology company focused on improving outcomes for cancer patients through multi-node inhibition of critical oncogenic pathways. [28, 70] The company's lead program, PIKTOR, is an investigational all-oral combination therapy targeting the PI3K/AKT/mTOR pathway. [28, 70]
3M change
-1.39%
Range high
$36.16
Congress · 90d
0
Insiders · 90d
0
Public signal layer
Who is disclosing activity in FTH?
Price
Showing 3M history. Source: FMP historical price full.
- Prev Close
- $27.34
- Day High
- $27.50
- Day Low
- $23.12
- 52w High
- $37.90
- 52w Low
- $7.20
- Volume
- 651,903
- Avg Volume
- Beta
- -0.308
* TTM/most recent where available
Company
- Ticker
- FTH
- Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- US
- CEO
- Anand Parikh
- Employees
- 29
- Website
- www.faeththerapeutics.com
Key Metrics
- Market Cap
- 34.2M
- P/E
- P/B
- P/S
- EV/EBITDA
- ROE
- Net Margin
- Div Yield
- FCF/Share
* TTM/most recent where available
DCF Valuation
Standard DCF
Levered DCF
Market Price
DCF vs Price (30D window)
Price uses last 30 days; DCF line holds latest value across the window.DCF line = solid green (latest value repeated across window), Price = dashed blue (daily closes).